Graham F. Pineo
University of Calgary
96 Papers
1.1K Citations
Graham F. Pineo is an academic researcher from University of Calgary. The author has contributed to research in topics: Low molecular weight heparin & Heparin. The author has an hindex of 28, co-authored 96 publications. Previous affiliations of Graham F. Pineo include Calgary General Hospital.
Chat about Author
Papers
•Journal Article
Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis against Deep Venous Thrombosis in Patients after Elective Hip Arthroplasty
Russell D. Hull,Graham F. Pineo,Paul D. Stein,Andrew F. Mah,Susan M. MacIsaac,Ola E. Dahl,Matthew S. Butcher,Rollin Brant,William A. Ghali,David Bergqvist,Gary E. Raskob +10 more
TL;DR: A systematic review is performed to provide clinicians with a practical pathway for translating clinical research into practice and suggest a need for extended out-of-hospital prophylaxis in patients undergoing total-hip replacement but not for patients undergoingtotal-knee replacement.
11
Thrombin inhibitors as anticoagulant agents.
Graham F. Pineo,Russell D. Hull +1 more
TL;DR: Clinical trials supporting the use of the specific antithrombin agents in the treatment of acute cardiac ischemic syndromes, the prevention and treatment of venous thromboembolism, and the management of heparin-induced thrombocytopenia are reviewed.
11
Therapeutic Use of Low Molecular Weight Heparins: Knowledge to Date and Their Application to Therapy
Russell D. Hull,Graham F. Pineo +1 more
TL;DR: The accumulating evidence indicates that certain LMW heparins administered subcutaneously may replace classic intravenous heparin therapy and will likely prove to be highly cost effective in patients with deep vein thrombosis.
11
Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism: Current Recommendations
Russell D. Hull,Graham F. Pineo +1 more
TL;DR: Hemarin—Low molecular weight heparin—Oral anti coagulants—Intermittent pneumatic compression—Graduated compression stockings—Deep vein thrombosis—Pulmonary embolism.
11
Low-molecular-weight heparin in the treatment of venous thromboembolism.
Russell D. Hull,Graham F. Pineo +1 more
TL;DR: The low-molecular-weight heparins have been found to be safe and effective in this clinical setting and have advantages over unfractionated heparin, including less serious and less frequent therapeutic complications.
10